top of page
Search

Poster #77: Jeffery Lin

3 days ago
1 min read

ContrastLEMBAS: Generalizable Drug-Target Prediction via Contrastive Learning


Jeffery Lin¹, Nikolaos Meimetis, PhD², Douglas A. Lauffenburger, PhD² ¹Department of Biology and the Department of Electrical Engineering and Computer Science (EECS), Massachusetts Institute of Technology ²Department of Biological Engineering, Massachusetts Institute of Technology

Predicting how a cell’s gene expression changes in response to a drug is crucial for understanding its mechanism of action (MoA), identifying potential off-target side effects, and accelerating drug discovery. However, many models struggle to generalize to drugs unseen during training, especially when those drugs are chemically dissimilar to those in the training set. LEMBAS, a mechanistic and biology-informed recurrent neural network, has been shown to effectively model intracellular signaling networks to predict transcriptional responses. Additional work has extended LEMBAS to drug transcriptional responses by inferring drug-target interactions, but it relies on a fixed drug-target space, limiting its ability to generalize to drugs or protein targets outside that space.


 
 
 

Recent Posts

See All
Poster Listing By Number

1 Alexandra Manchel PhD, Children’s Hospital of Philadelphia, Philadelphia, PA Gene expression dynamics of human and mouse craniofacial development at the single-cell level 2 Sydney Stanley PhD, Child

 
 
 
Poster #95: Chunwan Sun MS

Epigenetically constrained astrocyte states underlie prefrontal cortex vulnerability in Down syndrome–associated Alzheimer’s disease Chuhanwen Sun1,2*, Raina Thomas3*, Cherie Stringer5*, Kyriakitsa Ga

 
 
 
Poster #94: Muhammed Erguder PhD

Long-Read Sequencing and T2T-CHM13 Alignment Improve Structural Variant Discovery in an Expanding Alzheimer's Disease Cohort Muhammed F. Erguder, PhD (Columbia University); Dolly Reyes-Dumeyer (Columb

 
 
 

Comments


bottom of page